C. Saggia, “HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy: Carcinoma mammario HER2-positivo con metastasi cerebrali, lungorispondente alla terapia con lapatinib”, AboutOpen, vol. 4, no. 1, pp. 59–61, Jun. 2018.